SEOUL, South Korea, Oct. 22, 2026 /PRNewswire/ — Vespexx Inc., an AI-driven femtech company, today announced it has been named a Finalist for the Digital Health Hub Foundation’s Digital Health & AI Awards 2026, held at HLTH. Competing in the Rising Star track under the Women’s & Family Health category, Vespexx advanced from the Quarterfinalist stage announced earlier this fall, standing out among more than 1,300 submissions.
The Digital Health & AI Awards recognize organizations that use digital technology to improve healthcare services and patient outcomes, with a focus on speed, efficiency and equity of care.
Vespexx earned its Finalist distinction for Soonr, a preconception health platform that actively involves both partners in pregnancy planning from day one. Addressing the mental load often carried by women during the trying-to-conceive (TTC) journey, the Soonr app allows couples to seamlessly connect their accounts and navigate the process as a team. Within the platform, users can track cycle and lifestyle data, which is integrated with at-home hormone test results from the FDA-listed Surearly SMART Kit. By giving both partners the same timeline and updates, Soonr turns a traditionally isolating process into an informed, collaborative journey.
“For too long, the journey to pregnancy has been treated as a solitary burden, often leaving one partner overwhelmed and the other disconnected,” said Scarlett Joowon Jung, Co-CEO of Vespexx. “Soonr was built to close that gap by transforming preconception health into a shared, data-driven experience. This recognition from the Digital Health Hub Foundation validates our mission to make preconception health a shared journey, and we look forward to sharing our work on the HLTH stage as we accelerate our expansion in the U.S. market.”
“The transition from Quarterfinalist to Finalist is where the competition really gets exciting,” said Mark H. Goldstein, Chairman of the Digital Health Hub Foundation. “We’re seeing companies move beyond promising ideas to solutions that are changing how healthcare is delivered, experienced, and accessed. Our finalists represent an extraordinary range of innovation, and we can’t wait to bring their achievements to the stage at HLTH in November.”
Award winners will be announced on Monday, November 16, at HLTH USA at The Venetian in Las Vegas. The Women’s & Family Health category awards will be presented during the 2:30 PM PT ceremony at the Awards Pavilion.
Attendees of HLTH USA can also visit Vespexx at booth 1438-6 in the KIST SeoulBioHub Pavilion (Venetian Level 2, Exhibit Hall) to experience the Soonr platform firsthand.
About Digital Health Hub Foundation
Our mission is to help the world’s next best innovative healthcare companies scale and grow. Founded in 2017, on the campus of UCSF in San Francisco, our now 30,000 member community consists of thousands of early-to late-stage healthcare companies and highly qualified healthcare industry providers, payors, experts, mentors, investors, clinicians and researchers who participate in our annual awards ceremony where we bring together the industry to honor and validate the best of the best and celebrate the technological advances in healthcare and the impact it has.
About Vespexx
Vespexx is an AI femtech company based in Seoul, South Korea. The company is backed by strategic partner Sugentech (KOSDAQ: 253840), which brings 15 years of in vitro diagnostics R&D. Through this partnership, Vespexx operates with vertical integration across diagnostics R&D, hardware manufacturing, software and AI development, marketing and commercialization. Vespexx operates Soonr Health, a couples-focused preconception health platform, and previously launched Signaling, a couple’s app with more than 800,000 users. The company is currently expanding into the U.S. market. Learn more at https://soonr.health.
View original content to download multimedia:https://www.prnewswire.com/news-releases/vespexx-recognized-as-finalist-for-the-digital-health-hub-foundation-digital-health–ai-awards-2026-at-hlth-302916127.html
SOURCE Vespexx Inc.
